Showing results (21-30 of 389) with videos related to
Sort By:
Pageof 39
Nature Clinical Practice. Neurology|August 26, 2006
Drug Insight: interferon treatment in multiple sclerosisRuth Ann Marrie, Richard A RudickScience Translational Medicine|December 1, 2012
Time to integrate clinical and research informaticsIrene L Katzan, Richard A RudickScience Translational Medicine|April 5, 2013
Author response to comment on "time to integrate clinical and research informatics"Irene L Katzan, Richard A RudickBiologics : Targets & Therapy|August 27, 2009
Natalizumab for the treatment of relapsing multiple sclerosisRichard A Rudick, Michael A PanzaraMultiple Sclerosis Journal - Experimental, Translational and Clinical|May 4, 2023
Serum neurofilament light-chain levels and long-term treatment outcomes in relapsing-remitting multiple sclerosis patients: A post hoc analysis of the randomized CombiRx trialGary Cutter, Richard A Rudick, Carl de Moor, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|August 12, 2025
Lost in dichotomization: Preserving statistical power and sensitivity in MS cognitive researchJeroen Van Schependom, Gary CutterNeurology|April 28, 2010
Patient-centered outcomes: translating clinical efficacy into benefits on health-related quality of lifeDeborah Miller, Richard A Rudick, Michael HutchinsonContemporary Clinical Trials|January 5, 2011
Bayesian sample size determination under hypothesis testsXiao Zhang, Gary Cutter, Thomas BelinExpert Opinion on Biological Therapy|September 9, 2008
LINGO-1 antagonists as therapy for multiple sclerosis: in vitro and in vivo evidenceRichard A Rudick, Sha Mi, Alfred W SandrockMultiple Sclerosis (Houndmills, Basingstoke, England)|September 24, 2013
Multiple Sclerosis Outcome Assessments Consortium: Genesis and initial project planRichard A Rudick, Nicholas Larocca, Lynn D Hudson, et al.Pageof 39